MedTrace Logo

Uremic Toxins in the Intensive Care Units (ICU): Patients With Lactate Acidosis

NCT00752453 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2022-12-15

No results posted yet for this study

Summary

Study of the kinetics of uremic toxins in the ICU patients with acute renal failure, in order to optimize the dialysis dose: patients with lactate acidosis. The sampling of blood and dialysate will be done during dialysis with different durations (4, 6 and 8 h)

Conditions

  • Acute Renal Failure

Interventions

PROCEDURE

Dialysis during 4 hours

Blood and dialysate sampling

PROCEDURE

Dialysis during 6 hours

Blood and dialysate sampling

PROCEDURE

Dialysis during 8 hours

Blood and dialysate sampling

Sponsors & Collaborators

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Raymond Vanholder, MD, PhD · University Hospital, Ghent

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2013-10-04
Completion
2013-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00752453 on ClinicalTrials.gov